Key Events This Week
1 June: Stock opens with a significant gap down, closing at Rs.1,067.75 (-4.49%)
2 June: Technical momentum shifts amid mixed indicator signals, stock closes at Rs.1,036.55 (-2.92%)
3 June: Minor recovery with a 1.18% gain, closing at Rs.1,048.80
4 June: Slight decline of 0.56%, closing at Rs.1,042.95
5 June: Week ends with a 0.78% drop, closing at Rs.1,034.80
Senores Pharmaceuticals Surges 24.78%: 7 Key Factors Behind Its Market Rally
2026-06-13 09:04:02
Key Events This Week
8 June: Stock opens at Rs.1,006.15, down 2.77%
9 June: Intraday high of Rs.1,064.4 with 8.71% close gain
11 June: Intraday high near 52-week peak at Rs.1,193, 7.06% surge
12 June: New 52-week and all-time high at Rs.1,214.95, closing at Rs.1,291.25 (+11.35%)

136% Stock Return vs 97% Profit Growth: What Drives Senores Pharmaceuticals Ltd’s Multibagger Rally?
2026-06-12 18:40:07A 136.28% stock return in one year. A 97% growth in net profit over the same period. The gap between those two numbers — roughly 39 percentage points — is driven by the market's willingness to pay more for each rupee of Senores Pharmaceuticals Ltd's earnings. That willingness is the story behind this multibagger rally.
Read full news article
Senores Pharmaceuticals Ltd Surges 7.16% to New 52-Week High — Outperforms Sector by 6.26 Percentage Points
2026-06-12 11:47:31The Sensex advanced 1.13% on 12 Jun 2026, yet Senores Pharmaceuticals Ltd outpaced the broader market with a 7.16% gain, reaching a fresh 52-week and all-time high of Rs 1249.2. This 6.26 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific momentum surge rather than a mere market tailwind.
Read full news articleAnnouncement Under Regulation 30 Of SEBI (LODR) Regulations 2015
10-Jun-2026 | Source : BSESenores Pharmaceuticals Limited has informed the Exchange regarding update in terms of Regulation 30(5) of SEBI (LODR) Regulations 2015
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
10-Jun-2026 | Source : BSESenores Pharmaceuticals Limited has informed the Exchange regarding Cessation of Company Secretary and Compliance Offer w.e.f. June 10 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
09-Jun-2026 | Source : BSESenores Pharmaceuticals Limited has informed the Exchange regarding Analyst/Institutional Investor meet scheduled to be held on June 12 2026.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available











